References
1. Abdelghany T, Ganash M, Bakri MM, Elhussieny NI, Qanash H, Al-Rajhi
AM. A review SARS-CoV-2 the other face to SARS-CoV and MERS-CoV: About
future predictions. Biomedical Journal. 2020.
2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic
characterisation and epidemiology of 2019 novel coronavirus:
implications for virus origins and receptor binding. The Lancet.
2020;395(10224):565-74.
3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel
coronavirus from patients with pneumonia in China, 2019. New England
Journal of Medicine. 2020.
4. He J, Chen G, Jiang Y, Jin R, Shortridge A, Agusti S, et al.
Comparative infection modeling and control of COVID-19 transmission
patterns in China, South Korea, Italy and Iran. Science of the Total
Environment. 2020;747:141447.
5. Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RW, van der Meer
Y, Caly L, et al. SARS-coronavirus-2 replication in Vero E6 cells:
replication kinetics, rapid adaptation and cytopathology. The Journal of
general virology. 2020;101(9):925.
6. Perdikari TM, Murthy AC, Ryan VH, Watters S, Naik MT, Fawzi NL.
SARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human
hnRNPs. The EMBO journal. 2020;39(24):e106478.
7. Singh V, Luthra A, Chauhan R, Meena SC. Basic Virology and
Pathophysiology of COVID-19. Clinical Synopsis of COVID-19: Springer;
2020. p. 5-29.
8. Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure,
mechanism of action, antiviral drug promises and rule out against its
treatment. Journal of Biomolecular Structure and Dynamics. 2020:1-10.
9. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial
cluster of pneumonia associated with the 2019 novel coronavirus
indicating person-to-person transmission: a study of a family cluster.
The Lancet. 2020;395(10223):514-23.
10. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial
undocumented infection facilitates the rapid dissemination of novel
coronavirus (SARS-CoV-2). Science. 2020;368(6490):489-93.
11. Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB.
Dual respiratory virus infections. Clinical infectious diseases.
1997;25(6):1421-9.
12. Riou J, Althaus CL. Pattern of early human-to-human transmission of
Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.
Eurosurveillance. 2020;25(4):2000058.
13. Zhang N, Wang L, Deng X, Liang R, Su M, He C, et al. Recent advances
in the detection of respiratory virus infection in humans. Journal of
medical virology. 2020;92(4):408-17.
14. Khorramdelazad H, Kazemi MH, Najafi A, Keykhaee M, Emameh RZ, Falak
R. Immunopathological similarities between COVID-19 and influenza:
Investigating the consequences of Co-infection. Microbial pathogenesis.
2020:104554.
15. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T,
Davidson KW, et al. Presenting characteristics, comorbidities, and
outcomes among 5700 patients hospitalized with COVID-19 in the New York
City area. Jama. 2020.
16. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection
between SARS-CoV-2 and other respiratory pathogens. Jama. 2020.
17. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of
pneumonia patients coinfected with 2019 novel coronavirus and influenza
virus in Wuhan, China. Journal of medical virology. 2020.
18. Khodamoradi Z, Moghadami M, Lotfi M. Co-infection of coronavirus
disease 2019 and influenza: a report from Iran. 2020.
19. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects
of coronaviruses on the cardiovascular system: a review. JAMA
cardiology. 2020.
20. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza
and cardiovascular disease: is there a causal relationship? Texas Heart
Institute Journal. 2004;31(1):4.
21. Castillo EM, Coyne CJ, Brennan JJ, Tomaszewski CA. Rates of
coinfection with other respiratory pathogens in patients positive for
coronavirus disease 2019 (COVID-19). J Am Coll Emerg Physicians Open.
2020;1(4):592-6.
22. Yue H, Zhang M, Xing L, Wang K, Rao X, Liu H, et al. The
epidemiology and clinical characteristics of co-infection of SARS-CoV-2
and influenza viruses in patients during COVID-19 outbreak. J Med Virol.
2020;92(11):2870-3.
23. Ma L, Wang W, Le Grange JM, Wang X, Du S, Li C, et al. Coinfection
of SARS-CoV-2 and Other Respiratory Pathogens. Infect Drug Resist.
2020;13:3045-53.
24. Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Coinfection in
SARS-CoV-2 infected patients: Where are influenza virus and
rhinovirus/enterovirus? J Med Virol. 2020;92(10):1699-700.
25. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of
pneumonia patients coinfected with 2019 novel coronavirus and influenza
virus in Wuhan, China. J Med Virol. 2020;92(9):1549-55.
26. Hashemi SA, Safamanesh S, Ghasemzadeh-Moghaddam H, Ghafouri M,
Azimian A. High prevalence of SARS-CoV-2 and influenza A virus (H1N1)
coinfection in dead patients in Northeastern Iran. J Med Virol. 2020.
27. Ma S, Lai X, Chen Z, Tu S, Qin K. Clinical characteristics of
critically ill patients co-infected with SARS-CoV-2 and the influenza
virus in Wuhan, China. Int J Infect Dis. 2020;96:683-7.
28. Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, et al. Co-infection with
respiratory pathogens among COVID-2019 cases. Virus Res.
2020;285:198005.
29. Si Y, Zhao Z, Chen R, Zhong H, Liu T, Wang M, et al. Epidemiological
surveillance of common respiratory viruses in patients with suspected
COVID-19 in Southwest China. BMC Infect Dis. 2020;20(1):688.
30. Pormohammad A, Ghorbani S, Khatami A, Razizadeh MH, Alborzi E, Zarei
M, et al. Comparison of influenza type A and B with COVID-19: A global
systematic review and meta-analysis on clinical, laboratory and
radiographic findings. Reviews in Medical Virology.n/a(n/a):e2179.
31. Konala VM, Adapa S, Gayam V, Naramala S, Daggubati SR, Kammari CB,
et al. Co-infection with Influenza A and COVID-19. Eur J Case Rep Intern
Med. 2020;7(5):001656-.
32. Hashemi SA, Safamanesh S, Ghafouri M, Taghavi MR, Mohajer Zadeh
Heydari MS, Namdar Ahmadabad H, et al. Co-infection with COVID-19 and
influenza A virus in two died patients with acute respiratory syndrome,
Bojnurd, Iran. Journal of Medical Virology. 2020;92(11):2319-21.
33. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection
between SARS-CoV-2 and other respiratory pathogens. Jama.
2020;323(20):2085-6.
34. Konala VM, Adapa S, Gayam V, Naramala S, Daggubati SR, Kammari CB,
et al. Co-infection with Influenza A and COVID-19. Eur J Case Rep Intern
Med. 2020;7(5).
35. Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed
asymptomatic carrier transmission of COVID-19. Jama.
2020;323(14):1406-7.
36. Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and
pandemics: insights into the future of swine flu (H1N1). BMC medicine.
2009;7(1):1-8.
37. Sanche S, Lin Y, Xu C, Romero-Severson E, Hengartner N, Ke R. Early
Release-High Contagiousness and Rapid Spread of Severe Acute Respiratory
Syndrome Coronavirus 2-Volume 26, Number 7—July 2020-Emerging
Infectious Diseases journal-CDC.[cited 2020 May 3]. 2020.
38. Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Coinfection in
SARS-CoV-2 infected patients: Where are influenza virus and
rhinovirus/enterovirus? Journal of Medical Virology.
2020;92(10):1699-700.
39. Hageman JR. Current Status of the COVID-19 Pandemic, Influenza and
COVID-19 Together, and COVID-19 Viral Variants. Pediatric Annals.
2020;49(11):e448-e9.
40. Davis B, Rothrock AN, Swetland S, Andris H, Davis P, Rothrock SG.
Viral and atypical respiratory co‐infections in COVID‐19: a systematic
review and meta‐analysis. Journal of the American College of Emergency
Physicians open. 2020;1(4):533-48.